✦ LIBER ✦

Predictive value of the efficacy of glaucoma medications in regulatory trials: Phase I–III to post-marketing studies

✍ Scribed by Stewart, W C; Perry, Julian David

Book ID: 110036990
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 75 KB
Volume: 22
Category: Article
ISSN: 0950-222X
DOI: 10.1038/sj.eye.6702913

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Study to compare the efficacy and safety

Study to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis: a multicentre, randomised, double-blind, phase III trial

✍ S. M. Yim; J. H. Ko; Y. W. Lee; H. W. Kim; J. Y. Lee; N. I. Kim; Y. C. Kye; K. C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

The prognostic value of health-related q

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study

✍ Mauer, M; Stupp, R; Taphoorn, M J B; Coens, C; Osoba, D; Marosi, C; Wong, R; de 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

A multicenter, randomized, double-blind

A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial

✍ Daniel L. Rubin; Terry S. Desser; Richard Semelka; Jeffrey Brown; Hanh V. Nghiem 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views